Receiving Abortion Medication Through Mail Was Safe, Effective
JAMA · 2024
DOI: 10.1001/jama.2024.10330 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JAMA, 2024. Verfasst von Emily Harris. Hauptthemen laut MEDLINE: Abortifacient Agents, Abortion, Induced, Mifepristone, Misoprostol.
Abstract (Originalsprache)
Daniel Grossman, MD; Sarah Raifman, MSc; Natalie Morris, MPH; Andrea Arena, MD; Lela Bachrach, MD; Jessica Beaman, MD; M. Antonia Biggs, PhD; Amy Collins, MD, MS; Curtiss Hannum, CRNP; Stephanie Ho, MD; Susan M. Seibold-Simpson, PhD, MPH, RN; Mindy Sobota, MD, MS, MPhil; Kristina Tocce, MD, MPH; Eleanor B. Schwarz, MD; Marji Gold, MD
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Harris, E. (2024). Receiving Abortion Medication Through Mail Was Safe, Effective. JAMA. https://doi.org/10.1001/jama.2024.10330
Vancouver
Harris E. Receiving Abortion Medication Through Mail Was Safe, Effective. JAMA. 2024. doi:10.1001/jama.2024.10330
BibTeX
@article{Harris2024,
author = {Harris, Emily},
title = {Receiving Abortion Medication Through Mail Was Safe, Effective},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2024.10330}
}
EUVIMED